Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medication Lubricants for Oral Delivery of Drugs: Oral Processing Reduces Thickness, Changes Characteristics, and Improves Dissolution Profile.

Pharmaceutics·2024
Same author

The prevalence and perceived effectiveness of using a medication-swallowing lubricant in aged care facilities across Australia.

Aging medicine (Milton (N.S.W))·2023
Same author

Deprescribing Tool for Older PeoPle with Limited-life Expectancy (De-TOPPLE) version 1: Development and validation using a modified Delphi technique.

Basic & clinical pharmacology & toxicology·2023
Same author

A systematic review on methods for developing and validating deprescribing tools for older adults with limited life expectancy.

The International journal of pharmacy practice·2022
Same author

An exploration of hospital pharmacists' engagement with sustainability policy in the NHS England.

The International journal of pharmacy practice·2022
Same author

Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy.

Research in social & administrative pharmacy : RSAP·2022

Related Experiment Video

Updated: May 10, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Future-proofing the pharmacy profession in a hypercompetitive market.

Judith A Singleton1, Lisa M Nissen2

  • 1School of Pharmacy, University of Queensland, Brisbane, Australia; Asia Pacific Centre for Sustainable Enterprise, Griffith Business School, Griffith University, Brisbane, Australia.

Research in Social & Administrative Pharmacy : RSAP
|July 4, 2013
PubMed
Summary

Small Australian pharmacies can thrive by offering superior cognitive professional services (CPS) instead of competing on price. Focusing on niche markets and high-quality, differentiated services ensures patient loyalty and long-term profitability.

Keywords:
Community pharmacyDifferentiationHypercompetitionHypercompetitive pharmacy marketPharmacyProfessional servicesStrategy

More Related Videos

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

Related Experiment Videos

Last Updated: May 10, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

Area of Science:

  • Pharmacy Management
  • Health Economics
  • Business Strategy

Background:

  • The Australian pharmacy sector is highly competitive, challenging small independent pharmacies.
  • Cost leadership is often unsustainable for independent community pharmacies.
  • A need exists for alternative business models to ensure profitability.

Purpose of the Study:

  • To propose viable business models for small, independent Australian community pharmacies.
  • To explore differentiation and focused differentiation strategies based on cognitive professional services (CPS).
  • To identify pathways for achieving competitive advantage and long-term sustainability.

Main Methods:

  • Analysis of the Australian healthcare system and community pharmacy environment.
  • Proposal of business models centered on superior quality cognitive professional services (CPS).
  • Emphasis on market research to identify valued and payable services.

Main Results:

  • Differentiation or focused differentiation on CPS can be a viable alternative to cost leadership.
  • Superior quality CPS execution is crucial for patient satisfaction and loyalty.
  • Continuous development of core competencies is necessary for sustained competitive advantage.

Conclusions:

  • Independent community pharmacies can succeed by offering high-quality, differentiated cognitive professional services (CPS).
  • Strategic focus on niche markets and service quality is key to profitability.
  • Expertise in delivering CPS enables pharmacies to maintain a competitive edge.